Illumina Inc. (ILMN)

NASDAQ: ILMN · USD

$193

+3.51 (+1.9%)· Recorded snapshot

Coverage state: Latest published research available

Market snapshot recorded 2026-07-29 02:00 UTC. Latest published research analyzed 2026-05-13 · stale · sources unverified. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate a fresh ILMN analysis

The published report stays available while a new owner-requested analysis runs.

StockMarketAgent Research · Analyzed 2026-05-13

Our latest published analysis: ILMN rated Sell

Sell. The market prices Illumina for structural hyper-growth, while fundamentals indicate a mature compounder trajectory facing intense pricing pressure.

Fair value (mid)

$98.4 / share

$74.5 – $122

Upside to FV

-32.5%

from $193

Confidence

74/100

Moat

6/10

Read full analysis

Market cap	$22.0B
Revenue (ttm)	4.4B
Net income (ttm)	853M
EPS (ttm)	$5.52
Shares out	151.3M
P/E (trailing)	35.0x
P/E (forward)	24.6x
Volume	2,112,030
Beta	1.47
Price target	$173	-10.6%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 4.4B
Net income (ttm): 853M
EPS (ttm): $5.52
P/E (trailing): 35.0x
P/E (forward): 24.6x
Market cap: $22.0B

Item	P1	P2	P3	P4	P5	Trend
Period	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31	Trend
Revenue	—	$4.58B	$4.50B	$4.37B	$4.34B	-1.3%
Gross profit	—	$2.97B	$2.74B	$2.86B	$2.87B	-0.9%
Operating income	—	$354.0M	$-222.0M	$600.0M	$817.0M	+23.3%
Net income	—	$-4.40B	$-1.16B	$-1.22B	$850.0M	—
EPS (diluted)	$5.04	$-28.00	$-7.34	$-7.69	$5.45	+2.0%
EBITDA	—	$-3.92B	$-608.0M	$-725.0M	$1.46B	—
R&D	—	$1.32B	$1.35B	$1.17B	$967.0M	-7.5%
SG&A	—	$1.30B	$1.61B	$1.09B	$1.09B	-4.3%

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
AAPL	Apple Inc.	5T	41.0x	11.0x	104.3%	+6.8%	+58.6%	Sell
ABNB	Airbnb Inc.	90.8B	37.5x	7.2x	15.9%	+29.9%	+7.6%	Hold
ADBE	Adobe Inc.	104.7B	15.1x	4.2x	60.7%	+11.9%	-28.7%	Strong Buy
ABBV	AbbVie Inc.	465.2B	129.7x	7.4x	14.4%	+4.6%	+44.0%	Hold
ABT	Abbott Laboratories	186.9B	34.9x	4.0x	7.9%	+3.0%	-12.5%	Strong Buy
AMGN	Amgen Inc.	209.2B	27.0x	5.6x	19.1%	+8.1%	+32.5%	Strong Buy

All ILMN indicators

Market & fundamental data

Available fields

270

Groups with data

Currency

USD

Showing 270 of 270 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001110803
Company name	Illumina, Inc.
Country	United States
Country code	US
Cusip	452327109
Employees	10,080
Employees Change	-290%
Employees Change Percent	-2.8
Enterprise value	$30.6B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Diagnostics & Research
Industry PE	43.06
Industry PE Fwd	25.8
IPO Date	2000-07-28
Isin	US4523271090
Last refreshed	2026-07-29
Market cap	$29.2B
Market cap category	Large-Cap
Price	$193
Price currency	USD
Rev Per Employee	435,813.49x
Sector	Healthcare
Sector PE	45.29
Sector PE Fwd	23.97
Sic	3826
Symbol	ILMN
Website	https://www.illumina.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.92%
EV Earnings	35.86x
EV Sales Forward	6.61x
EV/EBIT	35.94x
EV/EBITDA	27.29x
EV/FCF	31.4x
EV/Sales	6.96x
FCF yield	3.34%
Forward P/E	35.89x
P/B ratio	10.96x
P/E ratio	34.98x
P/S ratio	6.65x
PE Ratio10 Y	54.01x
PEG ratio	3.5x
PS Forward	6.31x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	19.37%
EBITDA Margin	25.52%
FCF margin	22.17%
Gross margin	68.29%
Gross Profit	$3B
Gross Profit Growth	0.81%
Gross Profit Growth Q	5.13%
Gross Profit Growth3 Y	0.08%
Gross Profit Growth5 Y	4.78%
Net Income	$853M
Net Income Growth Q	2.29%
Net Income Growth Quarters	2%
Net Income Growth Years	1%
Net Income Growth5 Y	6.25%
Pretax Margin	24.15%
Profit Margin	19.42%
Profit Per Employee	$84,623
Profitable Quarters	$7
Profitable Years	1
ROA	8.68
Roa5y	2.88
ROCE	17.04
ROE	33.82
Roe5y	-11.3
ROIC	18.46
Roic5y	6.39

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	2.04%
Cagr15y	8.63%
Cagr1y	76.63%
Cagr20y	12.42%
Cagr3y	1.54%
Cagr5y	-16.4%
EPS Growth Q	6.1
EPS Growth Quarters	2
EPS Growth Years	1
EPS Growth5 Y	5.21
FCF Growth	11.19%
FCF Growth Q	20.67%
FCF Growth5 Y	1.82%
OCF Growth	12.8%
OCF Growth Q	20.42%
OCF Growth10 Y	5.01%
OCF Growth3 Y	69.9%
OCF Growth5 Y	0.85%
Revenue Growth	1.29x
Revenue Growth Q	4.8x
Revenue Growth Quarters	3x
Revenue Growth Years	0x
Revenue Growth3 Y	-0.41x
Revenue Growth5 Y	4.81x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.69
Assets	$6.6B
Cash	$1.2B
Current Assets	$2.7B
Current Liabilities	$1.6B
Debt	$2.5B
Debt EBITDA	$2.27
Debt Equity	$0.95
Debt FCF	$2.61
Equity	$2.7B
Interest Coverage	8.51
Liabilities	$3.9B
Long Term Assets	$3.8B
Long Term Liabilities	$2.3B
Net Cash	$-1.4B
Net Cash By Market Cap	$-4.76
Net Debt EBITDA	$1.24
Net Debt Equity	$0.52
Net Debt FCF	$1.43
Tangible Book Value	$962M
Tangible Book Value Per Share	$6.33
WACC	11.6

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.75
Inventory Turnover	2.43
Net Working Capital	$596M
Quick ratio	1.23
Working Capital	$1.2B
Working Capital Turnover	$3.65

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	2.67%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	22.39%
1Y total return	76.56%
200-day SMA	138.1
3Y total return	4.68%
50-day SMA	171.8
50-day SMA vs 200-day SMA	50over200
5Y total return	-59.16%
All Time High	555.8
All Time High Change	-65.28%
All Time High Date	2021-02-12
All Time Low	0.86
All Time Low Change	22,470.76%
All Time Low Date	2003-03-13
ATR	7.13
Beta	1.47
Beta1y	1.53
Beta2y	1.24
Ch YTD	47.13
High	195
High52	199.1
High52 Date	2026-07-23
High52ch	-3.09%
Low	187.7
Low52	88
Low52 Date	2025-10-14
Low52ch	119.3%
Ma50ch	12.3%
Premarket Change Percent	0.91
Premarket Price	$191
Premarket Volume	1,697
Price vs 200-day SMA	39.75%
RSI	59.03
RSI Monthly	65.2
RSI Weekly	74.14
Sharpe ratio	1.34x
Sortino ratio	2.53
Total Return	2.67%
Tr YTD	47.13
Tr15y	246.37%
Tr1m	9.31%
Tr1w	0.23%
Tr3m	50.16%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	20
Analyst Count Top	9
Analyst Price Target Top	$175
Analyst Ratings	Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$1.23
Earnings EPS Estimate Growth	3.36
Earnings Revenue Estimate	1,128,452,512x
Earnings Revenue Estimate Growth	6.56x
Operating Income	$885M
Operating Income Growth	37.64
Operating Income Growth Q	8.7
Operating Income Growth5 Y	8.67
Operating margin	20.15
Price target	$173
Price Target Change	$-10.6
Price Target Change Top	$-9.09

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	148,030,071%
Float Percent	97.84%
Net Borrowing	-5,000,000
Shares Insiders	2.08%
Shares Institutions	105.27%
Shares Out	151,300,000
Shares Qo Q	0%
Shares Yo Y	-2.67%
Short Float	5.91%
Short Ratio	3.64
Short Shares	5.78

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$712M
Adjusted OCF	866,000,000
Average Volume	1,749,166.95x
Bv Per Share	17.61
CAPEX	$-154M
Ch10y	18.94
Ch15y	236.6
Ch1m	9.31
Ch1w	0.23
Ch1y	76.56
Ch20y	909.6
Ch3m	50.16
Ch3y	1.73
Ch5y	-60.31
Ch6m	26.89
Change	1.85%
Change From Open	1.22
Close	189.5
Days Gap	0.63
Depreciation Amortization	270,000,000
Dollar Volume	407,579,549.4
Earnings Date	2026-07-30
Earnings Time	amc
EBIT	$851M
EBITDA	$1.1B
EPS	$5.52
F Score	6
FCF	$974M
FCF EV Yield	3.18x
FCF Per Share	$6.44
Financing CF	-800,000,000
Fiscal Year End	December
Founded	1,998
Goodwill	1,284,000,000
Graham Number	46.74931
Graham Upside	-75.78
Income Tax	$208M
Investing CF	-358,000,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-04-30
Last Report Date	2026-03-29
Last Split Date	2008-09-23
Last Split Type	Forward
Last10k Filing Date	2026-02-12
Lynch Fair Value	$34.47
Lynch Upside	-82.14
Ma150	145.2
Ma150ch	32.9%
Ma20	189.7
Ma20ch	1.75%
Net CF	-24,000,000
Next Earnings Date	2026-07-30
Open	190.7
Optionable	Yes
P FCF Ratio	29.98
P FCF Ratio SBC	41.01
P OCF Ratio	25.88
P OCF Ratio SBC	33.72
Position In Range	72.54
Ppne	1,126,000,000
Pre Close	189.5
Price Date	2026-07-28
Price EBITDA	$26.05
Ptbv Ratio	30.35
Relative Volume	1.21x
Revenue	4,393,000,000x
SBC By Revenue	5.96x
Share Based Comp	262,000,000
Tax By Revenue	4.73x
Tax Rate	19.6%
Tr20y	938.83%
Tr6m	26.89%
Us State	California
Volume	2,112,030
Z Score	3.83

Frequently asked questions

About this ILMN report

What is the latest published ILMN stock rating?

Illumina Inc. is shown with sell in the latest published report, analyzed 2026-05-13. The hub links directly to the full analysis surface where the dated rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ILMN analysis?

The full latest published report, analyzed 2026-05-13, lives at /stocks/ILMN/analysis. The bare ticker page summarizes that read and links to each analysis tab; earlier editions remain under /analysis/archive.

What fair-value range is used for ILMN?

The latest published report analyzed 2026-05-13 frames ILMN around USD 75 to USD 122. This is a dated valuation range, not a live market price; check the valuation, sensitivity, and bear-case tabs before making a decision.

How often is the ILMN page updated?

The hub selects the latest published stock report regardless of age and displays its analysis date (2026-05-13). Separately sourced market data is labeled with its own recorded timestamp and is never inferred from the report.

Illumina Inc. (ILMN)

Coverage state: Latest published research available

Generate a fresh ILMN analysis

Our latest published analysis: ILMN rated Sell

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · ILMN

Valuation

Profitability

Balance sheet

Trading

Position sizing & entry playbook

Next earnings

Sector percentile context

All ILMN indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on ILMN

Frequently asked questions